Nasdaq
$81.51▼ 0.91%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $4.53BShares out 55.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 10.15Pre-market26.10.15 19:598-KKey event#●●●
Hamilton Lane INC
Hamilton Lane has announced a leadership transition, appointing Hartley Rogers as Co-CEO alongside existing Co-CEO Juan Delgado-Moreira. Erik Hirsch, previously Co-CEO, has transitioned to the role of Executive Co-Chairman, where he will focus on driving the firm's long-term growth and strategic technology initiatives.…more
$81.51-0.91%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.18After-hours26.09.19 05:524Ownership
Hamilton Lane INC
Hamilton Lane INC insider Andrea Anigati filed a Form 4 report on September 18, 2026, regarding changes in beneficial ownership of securities as of September 16, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
$81.51-0.91%vs prev closeView filingShare - 9.18After-hours26.09.19 05:494Ownership
Hamilton Lane INC
Hamilton Lane INC executive Jeffrey Brian Armbrister filed a Form 4 on September 18, 2026, reporting a change in beneficial ownership of securities as of September 16, 2026. This filing serves as an official record of the insider's equity transaction.…more
$81.51-0.91%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoPre-market26.10.20 21:12Bullish#●●●#●●●
Cosette Pharmaceuticals Receives FDA Approval for EVOXAC
Cosette Pharmaceuticals has received FDA approval for a new oral solution formulation designed for patients with Sjögren’s disease. The product is expected to be commercially available by the end of 2026.…more
$81.51-0.91%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga